Skip to content

Clinical trials

Phase 1/2 Hyperglycemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperglycemia Phase: Phase 1/2 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20094
20203
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Unknown status2
Recruiting2
Suspended1
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adistem Ltd1
Admetsys Corporation1
Bows Pharmaceuticals AG1
David K Carroll1
Eledon Pharmaceuticals1
Kathleen Dungan1
Milton S. Hershey Medical Center1
Nambudripad's Allergy Research Foundation1
Ohio State University1
Oslo University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperglycemia14
Diabetes Mellitus7
Hypoglycemia4
Diabetes Mellitus, Type 13
Autoimmune Diseases1
Breast Neoplasms1
Diabetes Mellitus, Type 21
Diabetic Ketoacidosis1
Dyspepsia1
Endocrine System Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.